Other studies have also shown that SMA is usually used for the treatment or alternative therapy for acute promyelocytic leukemia, prostate cancer cells and other cell lines (Shen et al. 1997; Soignet et al. 1998; Maeda et al. 2001). Here, SMN1 is linked to prostate carcinoma.